S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

PCSA Processa Pharmaceuticals Inc

1.30

-0.03 (-2.26%)

Last Updated: 03:28:17

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (1 week ago) • Edgar (US Regulatory)

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
Tuesday 3 September 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Provides Product Pipeline and Financial Update
Wednesday 28 August 2024 (4 weeks ago) • GlobeNewswire Inc.

Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
Monday 19 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 August 2024 (2 months ago) • Edgar (US Regulatory)

More Processa Pharmaceuticals Inc News Articles

BNP Paribas Issuance BV

SavWatt USA (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions